#cxcr4receptor — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #cxcr4receptor, aggregated by home.social.
-
Norgine announces European Commission Marketing Authorisation for XOLREMDI® (mavorixafor), the first authorised treatment for patients with WHIM syndrome in the European Union
Approval follows a posi…
#Europe #EU #EuropeanCommission #(Mavorixafor) #CXCR4receptor #EuropeanMedicinesAgency #exceptionalcircumstances #hypogammaglobulinemia #marketingauthorisation #Norgine #Patients #pharmaceuticalcompany #primaryimmunodeficiency #WHIMsyndrome #whitebloodcells
https://www.europesays.com/europe/26264/